Searched for
VIVO BIOTECH LTD
Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%Budget 2026 underlines the government’s intent – in terms of the sectors it will focus on. Now, it is not all of a sudden that the governme...- Revised rules for biosimilar drugs enter the final stretchThe Indian government is refining biosimilar drug regulations, aligning with global standards to ensure stringent quality in research and m...
- Have Chinese on the menu: It's time to upgrade India's tech capabilities through collabs with companies, institutionsA US report warns of China's impending dominance in biotechnology, fueled by strategic investment and technology acquisition, while the US ...
- Driving innovation: India's foray into gene and cell therapiesIndia is progressing in cell and gene therapy. Research includes treatments for leukemia, hemophilia-A, sickle-cell anemia, and more.
- Immunity conferred by T-cells-based vaccine could last longerThe researchers from Pennsylvania State University, US, said that such a vaccine may provide long-lasting immunity against future emerging ...
- Sensex rises! These stocks gained over 10% on BSEIn the Nifty 50 index, 28 stocks ended in the green, while 21 stocks closed in the red in today's trade.
- Sensex rises! These stocks gained over 10% on BSEIn the Nifty 50 index, 15 stocks ended in the green, while 35 stocks closed in the red in today's trade.
- Bharat Biotech, Biovet, Sapigen Biologix sign collaborative research agreement with CSIR-IICTThe Master Collaborative Agreement (MCA) was signed here by Bharat Biotech International, Biovet, Sapigen Biologix with the IICT in the pre...
- Britain moves closer to COVID-19 vaccine trials that infect volunteersPreliminary work for the trials, which aim to speed up the process of determining the efficacy of a vaccine candidate, is being carried out...
- Drug maker Biocon buys back GE Capital's stake in Syngene International for Rs 215 croreSyngene offers integrated drug discovery & development services with capabilities in medicinal chemistry, biology, in vivo pharmacology & t...
- Biocon rules out listing of research services arm Syngene International this fiscalThe company, which was earlier working actively to list Syngene, said it will not happen this fiscal due to prevailing uncertainties.
- NRI scientists who turned research into successful businessesNot many Indians in US would risk turning their scientific research into successful businesses. Here is the story of the bravehearts who di...
- 37 SEZ developers including TCS, DLF, Parsvnath and others seek more time to implement projectsReflecting a lack of enthusiasm in special economic zones, 37 developers have sought more time from the govt for implementing their project...
- Govt plans stricter quality control for medical kitsManufacturers and importers of medical devices will soon have to face government's quality control norms as mandatory pre-requisite for per...
Load More
